The Food and Drug Administration has released final guidance on the post-market management of cybersecurity in medical devices. Of particular concern is the growing number of networked medical devices, the vulnerabilities of which could potentially put patient safety at risk.
“Networked medical devices, like other networked computer systems, incorporate software that may be vulnerable to cybersecurity threats,” states the FDA’s guidance. “The exploitation of vulnerabilities may represent a risk to health and typically requires continual maintenance throughout the product life cycle to assure an adequate degree of protection against such exploits. Proactively addressing cybersecurity risks in medical devices reduces the overall risk to health.”
Register or login for access to this item and much more
All Digital Insurance content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access